These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Tacrine. Alzheimer's disease and the cholinergic theory. A critical review and results of a new therapy. Boller F; Orgogozo JM Neurologia; 1995 May; 10(5):194-9. PubMed ID: 7619536 [No Abstract] [Full Text] [Related]
23. Cholinergic delirium and neurotoxicity associated with tacrine for Alzheimer's dementia. Trzepacz PT; Ho V; Mallavarapu H Psychosomatics; 1996; 37(3):299-301. PubMed ID: 8849507 [No Abstract] [Full Text] [Related]
25. Advances in diagnosing and treating Alzheimer's disease. Johns Hopkins Med Lett Health After 50; 1998 Sep; 10(7):4-6. PubMed ID: 9715123 [No Abstract] [Full Text] [Related]
27. Alzheimer's disease: a treatment in sight? Lovestone S; Howard R J Neurol Neurosurg Psychiatry; 1995 Dec; 59(6):566-7. PubMed ID: 7500092 [No Abstract] [Full Text] [Related]
28. [Alzheimer disease and related conditions. Increased knowledge. New preparations are on the way]. Basun H; Lannfelt L Lakartidningen; 1996 Dec; 93(50):4617-9. PubMed ID: 8999254 [No Abstract] [Full Text] [Related]
29. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease. Prescrire Int; 2003 Dec; 12(68):230-1. PubMed ID: 14986699 [TBL] [Abstract][Full Text] [Related]
30. Pharmacologic approaches to cognitive deficits in Alzheimer's disease. Peskind ER J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483 [TBL] [Abstract][Full Text] [Related]
31. [Alzheimer disease cannot be treated with Cognex]. Shafazand M Lakartidningen; 1996 Apr; 93(15):1406. PubMed ID: 8667714 [No Abstract] [Full Text] [Related]
32. [Tacrine and "profitability"]. Nygaard HA Tidsskr Nor Laegeforen; 1997 Feb; 117(5):726. PubMed ID: 9102968 [No Abstract] [Full Text] [Related]
34. Therapeutic trials using tacrine and other cholinesterase inhibitors. Gamzu ER; Thal LJ; Davis KL Adv Neurol; 1990; 51():241-5. PubMed ID: 2403716 [TBL] [Abstract][Full Text] [Related]
35. [More accurate diagnosis could identify patients suitable for tacrine therapy]. Andreasen N; Eriksson S; Karlsson I; Lindahl B; Lund M; Nordberg A; Wimo A; Winblad B; Astrand R Lakartidningen; 1996 Mar; 93(13):1200. PubMed ID: 8656831 [No Abstract] [Full Text] [Related]
36. Alzheimer's disease: will advances made in the past turn the tide? Semla TP Ann Pharmacother; 2007 Sep; 41(9):1494-6. PubMed ID: 17666576 [No Abstract] [Full Text] [Related]
37. Galantamine: new preparation. The fourth cholinesterase inhibitor for Alzheimer's disease. Prescrire Int; 2001 Dec; 10(56):180-1. PubMed ID: 11824442 [TBL] [Abstract][Full Text] [Related]
38. [Study on Alzheimer's disease and the animal disease model--special reference to acetylcholinergic system]. Ueki A; Taira H; Miyoshi I Seishin Shinkeigaku Zasshi; 1989; 91(10):736-50. PubMed ID: 2626496 [No Abstract] [Full Text] [Related]
39. Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease. Crismon ML Pharmacotherapy; 1998; 18(2 Pt 2):47-54; discussion 79-82. PubMed ID: 9543465 [TBL] [Abstract][Full Text] [Related]